Elisabetta Armani

8PUBLICATIONS
9CO-AUTHORS
Biomolecular modelling and designCellular nervous systemProteins and peptidesCheminformatics and quantitative structure-activity relationshipsPowder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 19, 2026
Discovery of a Novel Lung-Restricted ALK5 Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis.

|Nov 27, 2025
Design, Synthesis, and Biological Evaluation of the Novel Neutrophil Elastase Inhibitor CHF-6333 for the Inhaled Treatment of Bronchiectasis.

Elisabetta Armani, Andrea Rizzi, Daniela Miglietta

|Feb 19, 2025
Novel Cyclohexyl Amido Acid Antagonists of Lysophosphatidic Acid Type 1 Receptor for the Treatment of Pulmonary Fibrosis.

Marta Giuliani, Andrea Rizzi, Mafalda Pagano

|Nov 20, 2024
Design, Synthesis, and Activity of a Novel Series of Pyridazine-Based ALK5 Inhibitors.

Daniele Pala, Paolo Ronchi, Donatella Rescigno

|Aug 10, 2023
Optimization of M3 Antagonist-PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPD.

Andrea Rizzi, Gabriele Amari, Fausto Pivetti

|Apr 05, 2023
Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders.

Elisabetta Armani, Andrea Rizzi, Nicolò Iotti

Pageof 2

Frequent Collaborators

3 joint publications

Andrea Rizzi

2 joint publications

Marta Giuliani

2 joint publications

Paolo Ronchi

2 joint publications

Luca Venturi